3Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI[J]. Arch Dermatol, 1988, 123(6) : 869 -871.
4Chardon A, Moyal D, Hourseau C. Persistent pigment darkening as a method for the UVA Protection assessment of sunscreens. In : Rougier A, Schaefer H, eds. Protection of the skin against ultraviolet radiations[ M]. Paris: John Libbey Eurotext, 1998:132.
5Situm M, Kolic M, Bolanca Z, et al. Melasma-updated treatments [ J ]. Coil Antropol, 2011,35 ( Suppl 2 ) : 315 - 318.
6Vaneeta MS,Amit GP.Melasma:a comprehensive update: part I[J].J Am Acad Dermatol,2011,65(4):689-697;quiz 698.
7Kang WH,Yoon KH,Lee ES,et al.Melasma: histopathological characteristics in 56 Korean patients [J].Br J Dermatol, 2002,146(2):228-237.
8Passeron T. Melasma pathogenesis and influencing factors-an overview of the latest research [J].J Eur Aead Dermatol Venereol,2013,27 Suppl 1:5-6.
9Ortonne JP,Arellano I,Bemeburg M,et al.A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma [J].J Eur Aead Dermatol Venereol,2009, 23(11): 1254-1262.
10Robert L,Lawrence M.Estrogen receptor expression in melasma: results from facial skin of affected patients [J].J Drugs Dermatol,2008,7(5):463-465.
